United Therapeutics | Beneficio Operativo



Operating Profit Cambio Fecha
Amarin USD -25168000 24.64M 2024-09
Ardelyx USD 8.12M 5.89M 2024-12
Baxter International USD -435000000 590M 2024-12
Bayer EUR 3.53B 7.35B 2024-12
Biogen USD 441.4M 24.4M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Gilead Sciences USD 2.45B 1.56B 2024-12
GlaxoSmithKline GBP 696M 507M 2024-12
Halozyme Therapeutics USD 175.5M 12.3M 2024-12
Insmed USD -230414000 16.98M 2024-12
Intra Cellular Therapies USD -29197000 9.65M 2024-12
Ionis Pharmaceuticals USD -110823000 37.83M 2024-12
J&J USD 3.89B 549M 2024-12
Moderna USD -1246000000 1.18B 2024-12
Pfizer USD -409000000 5.57B 2024-12
PTC Therapeutics USD -62489000 7.98M 2024-12
Regeneron Pharmaceuticals USD 990.2M 189.3M 2024-12
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
Teva Pharmaceutical Industries USD 455M 506M 2024-12
United Therapeutics USD 357.7M 14.6M 2024-12
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12



United Therapeutics Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.